Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

Chemotherapy remains the standard care for HER2 mutated advanced non-small cell lung cancer (NSCLC) even though several targeted drugs showed promising results in preliminary stages. This study aimed to investigate the association of mutation variants with clinical features and the efficacy of chemo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Shuo Yang, Yan Wang, Chao Zhao, Xuefei Li, Qian Liu, Shiqi Mao, Yiwei Liu, Xiaofei Yu, Wanying Wang, Qinrun Tian, Yingying Pan, Anwen Xiong, Chen Bin, Guanghui Gao, Wei Li, Yayi He, Fengying Wu, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
Formaat: Artigo
Taal:Engels
Gepubliceerd in: 2021
Online toegang:https://doi.org/10.21037/tlcr-20-559
https://tlcr.amegroups.com/article/viewFile/49582/pdf
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

https://doi.org/10.21037/tlcr-20-559
https://tlcr.amegroups.com/article/viewFile/49582/pdf

Gelijkaardige items